Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Argos Therapeutics, Inc.

TRADE

NASDAQ: ARGSHealthcare / Biotechnology / USA
0.165-0.04-19.71%Vol 208 3901Y Perf -95.16%
Oct 16th, 2018 15:30
BID0.00 ASK0.00
Open0.18 Previous Close0.205
Pre-Market- After-Trading-
 - -%  - -%
Target Price
0.75 
Analyst Rating
— 0.00
Potencial %
355.65 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-100 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Buy
Price Range Ratio 52wk %
1.56 
Earnings Date
8th Nov 2018

Today's Price Range

0.1110.199

 

52wk Range

0.0755.80

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
62.97%
3 Months
6.13%
6 Months
-85.30%
1 Year
-95.16%
3 Years
-97.35%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ARGS0.165-0.0404-19.71
AAPL222.154.79002.20
GOOG1 121.2829.03002.66
MSFT111.003.40003.16
XOM81.200.38000.47
WFC53.730.49000.92
JNJ136.562.61001.95
FB158.785.26003.43
GE12.10-0.0500-0.41
JPM108.622.28002.14
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.30
Current Ratio 1.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -27.20
Leverage Ratio -10.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-207.00
EBITDA Margin-188.60
Pre-tax Profit Margin-5 083.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 4.00
PB Ratio 2.88
PS Ratios 0.33
Price to Cash Flow -
Price to Free Cash Flow -0.20
Cash Flow Per Share -3.37
Price to Tangible Book-0.31
Book Value per Share-0.77
Enterprise Value (in ths.)9 358
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)281.12
ROE last 12 Months 113.44
Return on Assets (5Y Avg) -239.96
ROA last 12 Months -76.38
Return on Capital (5Y Avg) -
ROC last 12 Months -186.76
Return on invested Capital Q -
Return on invested Capital Y-32.59
Assets Turnover0.10
Receivables Turnover66.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)7 658
Revenue per Share 0.72
Revenue Growth 3 Years 82.97
Revenue Growth 5 Years -9.32
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--1.05-
Q03 2017--0.10-
Q02 2017-0.13-0.21-61.54
Q01 2017--0.58-
Q03 2016-0.32-0.320.00
Q02 2016-0.40-0.48-20.00
Q01 2016-0.56-0.57-1.79
Q04 2015-0.86-0.842.33
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.15-7.14Negative
12/2017 QR-0.150.00-
12/2017 FY-1.08-22.73Negative
12/2018 FY-0.48-9.09Negative
Next Report Date8th Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume208 390
Shares Outstanding (in ths.)10 590
Trades Count49
Dollar Volume28 772
Avg. Volume399 456
Avg. Weekly Volume213 405
Avg. Monthly Volume92 916
Avg. Quarterly Volume54 522

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

64%36%

Bearish Bullish

63%38%

Bearish Bullish

63%38%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News

x